Login Contact Us
Jul 2018, Vol 6, Issue 3
Advanced Search
How do you find the scientific quality of the published articles on our web site?
Original Article
The Effect of Galega officinalis on Hormonal and Metabolic Profile in a Rat Model of Polycystic Ovary Syndrome
Seyed Hosein Abtahi-Eivari1, Maryam Moghimian1, Malihe Soltani1, Hamed Shoorei2, Reza Asghari2, Hossein Hajizadeh3, Majid Shokoohi2,4, Somayye Alami1, Faezeh Khalife Ghaderi5
1Department of Basic Sciences, Faculty of Medicine, Gonabad University of Medical Sciences, Gonabad, Iran
2Department of Anatomical Sciences, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
3Department of Nutrition, Faculty of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran
4Student Research Committee, Gonabad University of Medical Sciences, Gonabad, Iran
5Department of Midwifery, Faculty of Nursing and Midwifery, Iran University of Medical Sciences, Tehran, Iran

IJWHR 2018; 6: 276-282
DOI: 10.15296/ijwhr.2018.46
Viewed : 3380 times
Downloaded : 3807 times.

Keywords : Galega Officinalis, PCOS, Steroid hormones, Rat
Full Text(PDF) | Related Articles
Objectives: Polycystic ovary syndrome (PCOS) has been considered as one of the most common endocrine diseases among the females in their regenerative age with a prevalence range of 5 to 21%. However, the purpose of the present study was to investigate the protective effect of Galega officinalis on metabolic as well as hormonal parameters in a rodent model of PCOS.

Materials and Methods: Thirty-two Wistar female rats were used (n=8/group) in the study consisting of healthy control and experimental groups. The experimental groups were divided into 3 subgroups, including rats with PCOS which received no treatment (G1), PCOS group in which G. officinalis extract was administered daily at a dose of 200 mg/kg/orally (G2) for 2 weeks, and PCOS group in which G. officinalis extract was administered daily at a dose of 400 mg/kg/orally (G3) for 2 weeks. In all experimental groups, a single intramuscular injection of estradiol valerate led to inducing PCOS. After the end of treatment period, rats in all of the studied groups were anesthetized with ketamine/xylazine (5/1 mg/kg), then the blood samples obtained and their serum samples were applied for testing the fasting blood sugar (FBS), insulin, aromatase, and follicle-stimulating hormone (FSH), luteinizing hormone (LH), testosterone, and estrogen. The ovaries of rats were removed and fixed for histopathological examinations.

Results: The serum levels of FBS, insulin, LH, FSH, and testosterone significantly increased in G1 in comparison to healthy rats (P < 0.05), while they were all significantly decreased in the treated groups received G. officinalis extract compared to rats affected by PCOS (P < 0.05). Moreover, the serum level of estrogen and the serum activity of aromatase were both significantly decreased in G1 in comparison to healthy rats (P < 0.05), while in treated groups, they were significantly increased compared to G1 which received no treatment (P < 0.05). Moreover, the number of follicles in ovaries affected by PCOS decreased, while both concentrations of G. officinalis extract could prevent this phenomenon.

Conclusions: It seems that the extract of G. officinalis has a beneficial effect on the levels of the LH, FSH, testosterone, estradiol, aromatase, FBS, and insulin in alleviating the complications of PCOS.

Cite By, Google Scholar

Google Scholar

Articles by Moghimian M
Articles by Soltani M
Articles by Shoorei H
Articles by Asghari R
Articles by Hajizadeh H
Articles by Shokoohi M
Articles by Alami S
Articles by Khalife Ghaderi F


Articles by Maryam Moghimian
Articles by Malihe Soltani
Articles by Hamed Shoorei
Articles by Reza Asghari
Articles by Hossein Hajizadeh
Articles by Majid Shokoohi
Articles by Somayye Alami

Submit Paper
Online Submission System
IJWHR ENDNOTE ® Style Tutorials Publication Charge Women's Reproductive Health Research Center About Journal
Publication Information
Published Article Statistics